Neuregulins increase mitochondrial oxidative capacity and insulin sensitivity in skeletal muscle cells

Diabetes

Volumn 56, Issue 9, 2007, Pages 2185-2193

  Cantó, Carles ^a   Pich, Sara ^a   Paz, José C ^a   Sanches, Rosario ^a   Martínez, Vicente ^a   Orpinell, Meritxell ^a   Palacín, Manuel ^a   Zorzano, Antonio ^a   Gumà, Anna ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; HEREGULIN BETA1 177-244; LACTIC ACID; MITOCHONDRIAL PROTEIN; NEU DIFFERENTIATION FACTOR; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANIMAL CELL; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; FATTY ACID OXIDATION; GLUCOSE TRANSPORT; HEART MUSCLE CELL; INSULIN SENSITIVITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOTUBE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; INSULIN; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, MUSCLE; MUSCLE CELLS; MUSCLE, SKELETAL; NEUREGULIN-1; NEUREGULINS; OXYGEN CONSUMPTION; RATS;

EID: 34548394227     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-1726     Document Type: Article

References (48)

1. Falls DL: Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284:14-30, 2003
2. Jo SA, Zhu X, Marchionni MA, Burden SJ: Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression. Nature 373:158-161, 1995
3. Kim D, Chi S, Lee KH, Rhee S, Kwon YK, Chung CH, Kwon H, Kang MS: Neuregulin stimulates myogenic differentiation in an autocrine manner. J Biol Chem 274:15395-15400, 1999
4. Canto C, Suarez E, Lizcano JM, Grino E, Shepherd PR, Fryer LG, Carling D, Bertran J, Palacin M, Zorzano A, Guma A: Neuregulin signaling on glucose transport in muscle cells. J Biol Chem 279:12260-12268, 2004
5. Suarez E, Bach D, Cadefau J, Palacin M, Zorzano A, Guma A: A novel role of neuregulin in skeletal muscle: neuregulin stimulates glucose uptake, glucose transporter translocation, and transporter expression in muscle cells. J Biol Chem 276:18257-18264, 2001
6. Lebrasseur NK, Cote GM, Miller TA, Fielding RA, Sawyer DB: Regulation of neuregulin/ErbB signaling by contractile activity in skeletal muscle. Am J Physiol Cell Physiol 284:C1149-C1155, 2003
7. Canto C, Chibalin AV, Barnes BR, Glund S, Suarez E, Ryder JW, Palacin M, Zierath JR, Zorzano A, Guma A: Neuregulins mediate calcium-induced glucose transport during muscle contraction. J Biol Chem 281:21690-21697, 2006
8. Holloszy JO: Biochemical adaptations in muscle: effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 242:2278-2282, 1967
9. Hood DA: Invited Review: Contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol 90:1137-1157, 2001
10. Mole PA, Oscai LB, Holloszy JO: Adaptation of muscle to exercise: increase in levels of palmityl Coa synthetase, carnitine palmityltransferase, and palmityl Coa dehydrogenase, and in the capacity to oxidize fatty acids. J Clin Invest 50:2323-2330, 1971
11. Takahashi M, Hood DA: Chronic stimulation-induced changes in mitochondria and performance in rat skeletal muscle. J Appl Physiol 74:934-941, 1993
12. Ojuka EO, Jones TE, Han DH, Chen M, Holloszy JO: Raising Ca2+- in L6 myotubes mimics effects of exercise on mitochondrial biogenesis in muscle. FASEB J 17:675-681, 2003
13. Rose AJ, Richter EA: Skeletal muscle glucose uptake during exercise: how is it regulated? Physiology 20:260-270, 2005
14. Puigserver P, Spiegelman BM: Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24:78-90, 2003
15. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM: A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829-839, 1998
16. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115-124, 1999
17. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP: Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 106:847-856, 2000
18. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM: Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418:797-801, 2002
19. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM: Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2:e294, 2004
20. Ojuka EO, Jones TE, Han DH, Chen M, Wamhoff BR, Sturek M, Holloszy JO: Intermittent increases in cytosolic Ca2-+ stimulate mitochondrial biogenesis in muscle cells. Am J Physiol Endocrinol Metab 283:E1040-E1045, 2002
21. Ojuka EO, Jones TE, Nolte LA, Chen M, Wamhoff BR, Sturek M, Holloszy JO: Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca(2-+). Am J Physiol Endocrinol Metab 282:E1008-E1013, 2002
22. Holst D, Luquet S, Nogueira V, Kristiansen K, Leverve X, Grimaldi PA: Nutritional regulation and role of peroxisome proliferator-activated receptor delta in fatty acid catabolism in skeletal muscle. Biochim Biophys Acta 1633:43-50, 2003
23. Auestad N, Korsak RA, Morrow JW, Edmond J: Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J Neurochem 56:1376-1386, 1991
24. Ceddia RB, Sweeney G: Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells. J Physiol 555:409-421, 2004
25. Barish GD, Narkar VA, Evans RM: PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest 116:590-597, 2006
26. Lefebvre P, Chinetti G, Fruchart JC, Staels B: Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 116:571-580, 2006
27. Semple RK, Chatterjee VK, O'Rahilly S: PPAR gamma and human metabolic disease. J Clin Invest 116:581-589, 2006
28. Finck BN, Kelly DP: PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116:615-622, 2006
29. Nagase I, Yoshida S, Canas X, Irie Y, Kimura K, Yoshida T, Saito M: Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes. FEBS Lett 461:319-322, 1999
30. Son C, Hosoda K, Matsuda J, Fujikura J, Yonemitsu S, Iwakura H, Masuzaki H, Ogawa Y, Hayashi T, Itoh H, Nishimura H, Inoue G, Yoshimasa Y, Yamori Y, Nakao K: Up-regulation of uncoupling protein 3 gene expression by fatty acids and agonists for PPARs in L6 myotubes. Endocrinology 142:4189-4194, 2001
31. Hom FG, Goodner CJ: Insulin dose-response characteristics among individual muscle and adipose tissues measured in the rat in vivo with 3[H]2-deoxyglucose. Diabetes 33:153-159, 1984
32. Koivisto VA, Yki-Jarvinen H, DeFronzo RA: Physical training and insulin sensitivity. Diabete Metab Rev 1:445-481, 1986
33. Giraud MN, Fluck M, Zuppinger C, Suter TM: Expressional reprogramming of survival pathways in rat cardiocytes by neuregulin-1beta. J Appl Physiol 99:313-322, 2005
34. Grazette LP, Boecker W, Matsui T, Semigran M, Force TL, Hajjar RJ, Rosenzweig A: Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy. J Am Coll Cardiol 44:2231-2238, 2004
35. Bergeron R, Ren JM, Cadman KS, Moore IK, Perret P, Pypaert M, Young LH, Semenkovich CF, Shulman GI: Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab 281:E1340-E1346, 2001
36. Zong H, Ren JM, Young LH, Pypaert M, Mu J, Birnbaum MJ, Shulman GI: AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci U S A 99:15983-15987, 2002
37. Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, Gonzalez FJ, Ham J, Kang H, Peters JM, Evans RM: PPARdelta regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci U S A 103:3444-3449, 2006
38. Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M, Grimaldi PA: Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J 17:2299-2301, 2003
39. Schuler M, Ali F, Chambon C, Duteil D, Bornert JM, Tardivel A, Desvergne B, Wahli W, Chambon P, Metzger D: PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab 4:407-414, 2006
40. Fromm L, Burden SJ: Neuregulin-1-stimulated phosphorylation of GABP in skeletal muscle cells. Biochemistry 40:5306-5312, 2001
41. Hawley JA: Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabete Metab Res Rev 20:383-393, 2004
42. Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, Kelly DP, Holloszy JO: Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 16:1879-1886, 2002
43. Mootha VK, Handschin C, Arlow D, Xie X, St Pierre J, Sihag S, Yang W, Altshuler D, Puigserver P, Patterson N, Willy PJ, Schulman IG, Heyman RA, Lander ES, Spiegelman BM: Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci U S A 101:6570-6575, 2004
44. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273, 2003
45. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100:8466-8471, 2003
46. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI: Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140-1142, 2003
47. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-671, 2004
48. Lowell BB, Shulman GI: Mitochondrial dysfunction and type 2 diabetes. Science 307:384-387, 2005